-
Schedule Highlights from the Program Chairs: Sunday, April 19
Don’t miss the Opening Ceremony and Opening Plenary, the first New Drugs on the Horizon sessions, and more, say Program Committee Chairs Paul S. Mischel, MD, FAACR, and Alice T. Shaw, MD, PhD, FAACR.
-
Monday Plenary Session will examine the transformative potential of AI for cancer research and care
The third Plenary Session will feature speakers who are harnessing the power of artificial intelligence (AI) to augment approaches to complex cancer research.
-
New Drugs on the Horizon sessions will offer first look at diverse therapeutics
A three-part series will offer a glimpse at 12 innovative therapeutics that are being publicly disclosed for the very first time and may soon reshape the oncology landscape.
-
Schedule Highlights from the Program Chairs: Saturday, April 18
Don’t miss the first two Clinical Trials Minisymposia, the Discovery Science Plenary, and more, say Program Committee Chairs Paul S. Mischel, MD, FAACR, and Alice T. Shaw, MD, PhD, FAACR.
-
Opening Plenary to feature spectacular science from pioneering cancer researchers
Sunday’s Plenary Session will examine groundbreaking research across the cancer research continuum, from mechanistic insights to therapeutics to patient outcomes.
-
AACR Project GENIE sessions will showcase a new data model, use cases, and more
Multiple sessions will discuss studies powered by the publicly accessible AACR Project GENIE® pancancer registry and highlight its impact on advancing cancer research.
Meet the 2026 NextGen Stars
